Centessa Pharmaceuticals (CNTA) Leases (2023 - 2025)
Historic Leases for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q3 2025 value amounting to $10.3 million.
- Centessa Pharmaceuticals' Leases fell 844.01% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 844.01%. This contributed to the annual value of $11.0 million for FY2024, which is 756.25% down from last year.
- Per Centessa Pharmaceuticals' latest filing, its Leases stood at $10.3 million for Q3 2025, which was down 844.01% from $10.5 million recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' Leases ranged from a high of $12.3 million in Q2 2023 and a low of $10.3 million during Q3 2025
- Moreover, its 3-year median value for Leases was $11.5 million (2024), whereas its average is $11.4 million.
- As far as peak fluctuations go, Centessa Pharmaceuticals' Leases crashed by 487.8% in 2024, and later plummeted by 844.01% in 2025.
- Quarter analysis of 3 years shows Centessa Pharmaceuticals' Leases stood at $11.9 million in 2023, then fell by 7.56% to $11.0 million in 2024, then fell by 6.52% to $10.3 million in 2025.
- Its Leases stands at $10.3 million for Q3 2025, versus $10.5 million for Q2 2025 and $10.8 million for Q1 2025.